Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients and titration of naloxone

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 13, Issue 2, 2013, Pages 149-151

  Boland, Jason ^c   Boland, Elaine ^a   Brooks, David ^b  

^a HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^b CHESTERFIELD ROYAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Cancer pain; Naloxone; Opioid; Respiratory depression

Indexed keywords

DIAMORPHINE; MORPHINE; NALOXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; OPIATE;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREATHING RATE; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; DYSPNEA; FEMALE; HIP PAIN; HUMAN; HYPOXIA; LUNG CANCER; MALE; OXYGEN SATURATION; OXYGENATION; PROSTATE CANCER; RESPIRATION DEPRESSION; RESPIRATORY FUNCTION; STIMULATION; TERMINAL CARE; BONE TUMOR; CANCER PAIN; CHEMICALLY INDUCED DISORDER; LUNG TUMOR; METASTASIS; OXYGEN THERAPY; PAIN; PATHOLOGY; PROSTATE TUMOR; RESPIRATORY FAILURE; WITHDRAWAL SYNDROME;

CANCER PAIN; NALOXONE; OPIOID; RESPIRATORY DEPRESSION;

ANALGESICS, OPIOID; BONE NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; OXYGEN INHALATION THERAPY; PAIN; PROSTATIC NEOPLASMS; RESPIRATORY INSUFFICIENCY; SUBSTANCE WITHDRAWAL SYNDROME;

MLCS; MLOWN;

EID: 84884518838     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.13-2-149     Document Type: Article

References (15)

1. Feldman JL, Del Negro CA. Looking for inspiration: new perspectives on respiratory rhythm. Nat Rev Neurosci 2006;7:232-42.
2. Pattinson KT, Mitsis GD, Harvey AK et al. Determination of the human brainstem respiratory control network and its cortical connections in vivo using functional and structural imaging. Neuroimage 2009;44:295-305.
3. NHS Scotland. Palliative care guidelines - naloxone, 2009. www.palliativecareguidelines.scot.nhs.uk/pain-management/naloxone.asp [Accessed 29 January 2013].
4. Twycross R, Wilcock A. Palliative care formulary. 4th ed. Nottingham: Palliativedrugs, 2011.
5. Cronin AJ, Aucutt-Walter NM, Budinetz T et al. Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers. Br J Anaesth 2003;91:805-9.
6. Lister N, Warrington S, Boyce M et al. Pharmacokinetics, safety, and tolerability of ascending doses of sublingual fentanyl, with and without naltrexone, in Japanese subjects. J Clin Pharmacol 2011;51:1195-204.
7. Clemens KE, Klaschik E. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. J Pain Symptom Manage 2007;33:473-81.
8. Clemens KE, Quednau I, Klaschik E. Is there a higher risk of respiratory depression in opioid-naive palliative care patients during symptomatic therapy of dyspnea with strong opioids? J Palliat Med 2008;11:204-16.
9. Bouillon T, Bruhn J, Roepcke H, Hoeft A. Opioid-induced respiratory depression is associated with increased tidal volume variability. Eur J Anaesthesiol 2003;20:127-33.
10. Barbour SJ, Vandebeek CA, Ansermino JM. Increased tidal volume variability in children is a better marker of opioid-induced respiratory depression than decreased respiratory rate. J Clin Monit Comput 2004;18:171-8.
11. Electronic Medicines Compendium. Summary of Product Characteristics - Naloxone, 2008. www.medicines.org.uk/EMC/medicine/21095/SPC/ Naloxone+400+micrograms+ml+solution+for+Injection+(hameln [Accessed 29 January 2013].
12. American Pain Society. Principles of analgesic use in the treatment of acute pain and cancer pain. Glenview, Illinois: American Pain Society, 2008.
13. NHS Lothian Joint Formulary. Section 15.1.7. Antagonists for central and respiratory depression, 2011. www.ljf.scot.nhs.uk/LothianJointFormularies/Adult/ 15.0/15.1/15.1.7/Pages/default.aspx [Accessed 29 January 2013].
14. Dahan A, Yassen A, Bijl H et al. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br J Anaesth 2005;94:825-34.
15. Dahan A, Yassen A, Romberg R et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth 2006;96:627-32.